Cargando…
Application of Next Generation Sequencing for personalized medicine for sudden cardiac death
Sudden cardiac death (SCD) is a serious public health problem. In the United States, more than 300,000 people are affected by SCD every year. Significantly, sudden deaths represent 20% of the total mortality and 50% of cardiovascular mortality in Western countries. In addition, SCD constitutes one o...
Autores principales: | Morini, Elena, Sangiuolo, Federica, Caporossi, Daniela, Novelli, Giuseppe, Amati, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345839/ https://www.ncbi.nlm.nih.gov/pubmed/25784923 http://dx.doi.org/10.3389/fgene.2015.00055 |
Ejemplares similares
-
Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes
por: Pucci, Sabina, et al.
Publicado: (2019) -
The human rs1050286 polymorphism alters LOX‐1 expression through modifying miR‐24 binding
por: Morini, Elena, et al.
Publicado: (2015) -
Novel Indel Variation of NPC1 Gene Associates With Risk of Sudden Cardiac Death
por: Zhao, Wenfeng, et al.
Publicado: (2022) -
Next-Generation Sequencing in Post-mortem Genetic Testing of Young Sudden Cardiac Death Cases
por: Lahrouchi, Najim, et al.
Publicado: (2016) -
Next-generation sequencing improves precision medicine in hearing loss
por: Imizcoz, T., et al.
Publicado: (2023)